Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/643
| Subject | Predicate | Object | Context |
|---|---|---|---|
| dailymed-drugs:643 | rdf:type | http://www4.wiwiss.fu-berli... | lld:dailymed |
| dailymed-drugs:643 | rdf:type | dailymed-instance:drugs | lld:dailymed |
| dailymed-drugs:643 | rdfs:label | Metoprolol Tartrate (Tablet, Film Coated) | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:dosage | Hypertension:<br/>Angina Pectoris:<br/>Myocardial Infarction:<br/>Early Treatment:<br/>Late Treatment: | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:clinicalP... | Pharmacokinetics: | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:activeIng... | dailymed-ingredient:Metopro... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:contraind... | Hypertension and Angina:<br/>Myocardial Infarction: | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:boxedWarn... | Ischemic Heart Disease: Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. When discontinuing chronically administered metoprolol, particularly in patients with ischemic heart disease, the dosage should be gradually reduced over a period of 1 to 2 weeks and the patient should be carefully monitored. If angina markedly worsens or acute coronary insufficiency develops, metoprolol administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstableangina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician's advice. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue metoprolol therapy abruptly even in patients treated only for hypertension.<br/>Bronchospastic Diseases:<br/>Major Surgery:<br/>Diabetes and Hypoglycemia:<br/>Pheochromocytoma:<br/>Thyrotoxicosis: | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:activeMoi... | dailymed-ingredient:Metopro... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:inactiveI... | dailymed-ingredient:Talc | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:inactiveI... | dailymed-ingredient:Corn_St... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:inactiveI... | dailymed-ingredient:Magnesi... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:inactiveI... | dailymed-ingredient:Colloid... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:inactiveI... | dailymed-ingredient:Polysor... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:inactiveI... | dailymed-ingredient:Titaniu... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:inactiveI... | dailymed-ingredient:Microcr... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:inactiveI... | dailymed-ingredient:Polyeth... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:inactiveI... | dailymed-ingredient:Hyprome... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:inactiveI... | dailymed-ingredient:Sodium_... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:inactiveI... | dailymed-ingredient:Sodium_... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:precautio... | General:<br/>Information for Patients:<br/>Drug Interactions:<br/>General Anesthetics:<br/>CYP2D6 Inhibitors:<br/>Clonidine:<br/>Carcinogenesis, Mutagenesis, Impairment of Fertility:<br/>Nursing Mothers:<br/>Pediatric Use:<br/>Geriatric Use: | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:overdosag... | Signs and Symptoms:<br/>Treatment: | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:genericMe... | Metoprolol Tartrate | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:fullName | Metoprolol Tartrate (Tablet, Film Coated) | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:adverseRe... | Hypertension and Angina:<br/>Myocardial Infarction:<br/>Potential Adverse Reactions: | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:warning | Hypertension and Angina:<br/>Cardiac Failure:<br/>In Patients Without a History of Cardiac Failure:<br/>Ischemic Heart Disease: Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. When discontinuing chronically administered metoprolol, particularly in patients with ischemic heart disease, the dosage should be gradually reduced over a period of 1 to 2 weeks and the patient should be carefully monitored. If angina markedly worsens or acute coronary insufficiency develops, metoprolol administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstableangina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician's advice. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue metoprolol therapy abruptly even in patients treated only for hypertension.<br/>Myocardial Infarction:<br/>Cardiac Failure:<br/>Bradycardia:<br/>AV Block:<br/>Hypotension:<br/>Bronchospastic Diseases: | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:indicatio... | Hypertension:<br/>Angina Pectoris:<br/>Myocardial Infarction: | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:represent... | http://www4.wiwiss.fu-berli... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:routeOfAd... | http://www4.wiwiss.fu-berli... | lld:dailymed |
| dailymed-drugs:643 | dailymed-instance:name | Metoprolol Tartrate | lld:dailymed |
| http://www4.wiwiss.fu-berli... | dailymed-instance:producesD... | dailymed-drugs:643 | lld:dailymed |